Mindbio Therapeutics Corp. (MBIO) Income Statement
10 Followers
Mindbio Therapeutics Corp. Income Statement
Last quarter (Q3 2024), Mindbio Therapeutics Corp.'s total revenue was AU$433.23K, an increase of Infinity% from the same quarter last year. In Q3, Mindbio Therapeutics Corp.'s net income was AU$76.82K. See Mindbio Therapeutics Corp.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Jun 23
Total Revenue
-
Cost of Revenue
-
Gross Profit
-
Operating Expense
AU$ 3.61M
Operating Income
AU$ -3.61M
Net Non Operating Interest Income Expense
AU$ 451.30K
Other Income Expense
AU$ -668.23K
Pretax Income
AU$ -4.29M
Tax Provision
-
Earnings From Equity Interest Net Of Tax
-
Net Income Common Stockholders
AU$ -4.29M
Basic EPS
AU$ -0.04
Diluted EPS
AU$ -0.04
Basic Average Shares
AU$ 110.14M
Diluted Average Shares
AU$ 110.14M
Dividend Per Share
-
Total Operating Income As Reported
-
Reported Normalized Basic E P S
-
Reported Normalized Diluted E P S
-
Rent Expense Supplemental
-
Total Expenses
AU$ 3.61M
Net Income From Continuing And Discontinued Operation
AU$ -4.29M
Normalized Income
AU$ -3.15M
Interest Expense
-
EBIT
AU$ -3.84M
EBITDA
AU$ -3.84M
Currency in AUD
Mindbio Therapeutics Corp. Earnings and Revenue History